Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1982 1
1983 1
1985 3
1986 5
1987 4
1988 1
1989 1
1990 2
1991 5
1992 4
1993 6
1994 11
1995 9
1996 14
1997 13
1998 22
1999 13
2000 15
2001 15
2002 18
2003 21
2004 16
2005 25
2006 29
2007 25
2008 41
2009 32
2010 42
2011 48
2012 45
2013 52
2014 44
2015 55
2016 53
2017 42
2018 44
2019 58
2020 58
2021 76
2022 57
2023 53
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

924 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Denkert C, Seither F, Schneeweiss A, Link T, Blohmer JU, Just M, Wimberger P, Forberger A, Tesch H, Jackisch C, Schmatloch S, Reinisch M, Solomayer EF, Schmitt WD, Hanusch C, Fasching PA, Lübbe K, Solbach C, Huober J, Rhiem K, Marmé F, Reimer T, Schmidt M, Sinn BV, Janni W, Stickeler E, Michel L, Stötzer O, Hahnen E, Furlanetto J, Seiler S, Nekljudova V, Untch M, Loibl S. Denkert C, et al. Among authors: link t. Lancet Oncol. 2021 Aug;22(8):1151-1161. doi: 10.1016/S1470-2045(21)00301-6. Epub 2021 Jul 9. Lancet Oncol. 2021. PMID: 34252375
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response.
Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, Furlanetto J, Zahm DM, Hanusch C, Thomalla J, Jackisch C, Staib P, Link T, Rhiem K, Solbach C, Fasching PA, Nekljudova V, Denkert C, Untch M; GBG and AGO-B. Loibl S, et al. Among authors: link t. Ann Oncol. 2022 Nov;33(11):1149-1158. doi: 10.1016/j.annonc.2022.07.1940. Epub 2022 Aug 9. Ann Oncol. 2022. PMID: 35961599 Free article. Clinical Trial.
Radiology of Osteoporosis.
Link TM. Link TM. Can Assoc Radiol J. 2016 Feb;67(1):28-40. doi: 10.1016/j.carj.2015.02.002. Epub 2015 Jun 21. Can Assoc Radiol J. 2016. PMID: 26105503 Free article. Review.
Prestructural cartilage assessment using MRI.
Link TM, Neumann J, Li X. Link TM, et al. J Magn Reson Imaging. 2017 Apr;45(4):949-965. doi: 10.1002/jmri.25554. Epub 2016 Dec 26. J Magn Reson Imaging. 2017. PMID: 28019053 Review.
Using AI to Improve Radiographic Fracture Detection.
Link TM, Pedoia V. Link TM, et al. Radiology. 2022 Mar;302(3):637-638. doi: 10.1148/radiol.212364. Epub 2021 Dec 21. Radiology. 2022. PMID: 34931864 Free PMC article. No abstract available.
Imaging of Overuse Injuries of the Hip.
Baal JD, Cecil KL, Patel R, O'Brien M, McGill K, Link TM. Baal JD, et al. Among authors: link tm. Radiol Clin North Am. 2023 Mar;61(2):191-201. doi: 10.1016/j.rcl.2022.10.003. Epub 2022 Dec 13. Radiol Clin North Am. 2023. PMID: 36739141 Review.
Advanced Imaging in Osteoarthritis.
Li Q, Amano K, Link TM, Ma CB. Li Q, et al. Among authors: link tm. Sports Health. 2016 Sep;8(5):418-28. doi: 10.1177/1941738116663922. Epub 2016 Aug 10. Sports Health. 2016. PMID: 27510507 Free PMC article. Review.
Skeletal Radiology: the year in review 2019.
Kransdorf MJ, Link TM, Palmer WE, Fitzhugh VA. Kransdorf MJ, et al. Among authors: link tm. Skeletal Radiol. 2020 Aug;49(8):1179-1181. doi: 10.1007/s00256-020-03469-x. Epub 2020 May 28. Skeletal Radiol. 2020. PMID: 32468098
924 results